News

Ideal Power Achieves Key Milestone with SSCB Technology

Ideal Power Achieves Key Milestone with SSCB Technology

Ideal Power's Groundbreaking Achievement in Solid-State Circuit Breakers

Ideal Power Inc. (NASDAQ: IPWR) has made significant strides by successfully completing all deliverables connected to their first design win for solid-state circuit breakers (SSCBs), achieving this impressive feat three months ahead of schedule. This design win demonstrates the strong potential of their B-TRAN® technology in revolutionizing circuit protection systems.

Partnership with Leading Circuit Protection Manufacturer

The company has entered into a joint development agreement aimed at integrating their multi-device B-TRAN® semiconductor solution into SSCBs alongside a prominent circuit protection equipment manufacturer. This collaboration is particularly noteworthy as it opens avenues into multiple high-demand markets, including data centers, renewable energy, and energy storage.

Technical Innovations Driving Efficiency

In this partnership, Ideal Power has equipped the customer's SSCB prototypes with B-TRAN® devices and complementary circuitry. A crucial advantage of B-TRAN® technology is its ability to replace traditional silicon carbide (SiC) devices, resulting in a remarkable more than 60% reduction in total energy losses. This efficiency is paired with bidirectional capabilities, solving long-standing challenges faced by conventional breakers.

Accelerated Market Introduction

The completed SSCB prototypes were immediately sent to the customer for comprehensive testing. This rapid progression will help the manufacturer market their ultra-low loss circuit breaker sooner than anticipated, ensuring they stay competitive within the electric distribution market.

B-TRAN® Technology: A Game Changer in Circuit Protection

As Dan Brdar, President and CEO of Ideal Power, expressed, this accomplishment underscores essential validation of the B-TRAN® technology. Being the first to offer such an advanced SSCB positions any participating manufacturer advantageously within a marketplace eager for groundbreaking solutions. The expectations surrounding its launch are promising, potentially leading to further engagements and design wins with international companies interested in incorporating this innovative technology into their offerings.

Significant Revenue Potential

According to estimates from the customer, Ideal Power foresees substantial revenue opportunities from the initial B-TRAN®-based product, potentially amounting to hundreds of thousands of dollars within its first year of sales. This figure may escalate over a million dollars as the product matures in the market. Furthermore, the first SSCB incorporating B-TRAN® is set to target sectors strongly focused on renewable energy, energy storage solutions, and utility networks.

Expanding Product Range and Opportunities

The customer intends to develop a family of B-TRAN®-enabled SSCBs suited for various applications. Future products could cater to diverse needs, from enhancing data center efficiency to bolstering electric vehicle infrastructures. The wide application potential solidifies the B-TRAN® technology as a keystone innovation for various industries.

About Ideal Power Inc.

Ideal Power Inc. (NASDAQ: IPWR) stands out as an innovative force in the semiconductor power switch industry. The company's flagship B-TRAN® technology drives significant advancements in energy management, offering sustainable solutions for electric vehicles, charging stations, renewable energy systems, and beyond. Ideal Power remains committed to enhancing AC power management through its patented semiconductor technology.

Frequently Asked Questions

What is Ideal Power's recent achievement?

Ideal Power has successfully completed all deliverables related to their first design win for solid-state circuit breakers, ahead of the scheduled timeline.

What is the B-TRAN® technology?

B-TRAN® is a patented bidirectional semiconductor switch developed by Ideal Power that significantly reduces energy losses and improves efficiency in circuit applications.

How does the partnership benefit Ideal Power?

The partnership allows Ideal Power to integrate their technology into high-demand markets, accelerating the development and marketing of innovative circuit protection solutions.

What markets will the B-TRAN®-enabled SSCBs target?

The SSCBs will primarily target renewable energy sectors, energy storage providers, and utility networks, with potential applications expanding to data centers and electric vehicles.

What sales expectations does Ideal Power have?

Initial sales could generate hundreds of thousands of dollars, with projections indicating the potential for over a million dollars as the product gains market traction.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Paulex Bio's PAL-119 Trials: A New Diabetes Frontier

Updated Category News Views 80

Chasing the Holy Grail in Diabetes Treatment The pursuit of a true remedy for diabetes is almost like hunting for the mythical beast—a challenge that's left plenty of contenders biting the dust over the years. Yet, here's Paulex Bio jumping right into the fray with their groundbreaking PAL-119. They're not just peddling another temporary fix like most on the market;...

Continue Reading
PRG Projects' London Studio Elevates Live Entertainment

Updated Category News Views 172

A New Stage for Creativity in London When the curtain rises on a fresh idea, it's often the unknowns that make or break a production. Now, with PRG Projects unveiling their spanking new Project Studio in London, the tech and creative worlds might just bridge their gap tighter than a stage curtain before showtime. London Welcomes PRG's Innovative Hub This isn't just...

Continue Reading
TriMas Streamlines Portfolio with Rapak Sale

Updated Category News Views 48

TriMas Sheds Rapak: A Strategic Move Here's a twist worth dissecting: TriMas Corporation (NASDAQ: TRS) has offloaded its subsidiary Rapak, LLC to the German industrial packaging giant, Ringmetall SE. This isn't just a business shuffle—it's a calculated pivot with eyes on sharpening the core business blade. As they announced from Bloomfield Hills, Michigan, this move...

Continue Reading
i-80 Gold's Q3 2026: Production Plans Unveiled

Updated Category News Views 31

Gold Miners on the Move: Eye on i-80 Wake up and smell the gold, folks. i-80 Gold is ramping up to increase its yearly gold production targets, aiming for a hefty 150,000 to 200,000 ounces by 2028. Now, if you’ve been around the block like me, you know these are the kind of numbers that get investors either shifting in their chairs or springing to their feet. A Brief...

Continue Reading
RD Technologies Ramps Up Cross-Border Payments

Updated Category News Views 185

RD Technologies: Revving Up the Payment Game RD Technologies is at it again, jazzing up its game in the cross-border payments realm. One can almost smell the digits doing a tango across continents—particularly as Hong Kong's financial warriors set their sights on beefing up trade between Africa and Asia. New Alliances in the Payment Arena Here's a roadmap: Connect the...

Continue Reading
Ascletis Showcases Bold Moves in Obesity Drug Arena

Updated Category News Views 163

If you’ve been watching the developments in the world of obesity treatments, Ascletis Pharma is a name you'd do well not to ignore. With ObesityWeek 2026 on the horizon, these folks aren’t just talking—they’re putting their preclinical cards on the table and they’re noteworthy. Unveiling Future Contenders Ascletis is gearing up to present some of their...

Continue Reading
Lincoln Avenue's Bold New Move: Affordable Senior Living

Updated Category News Views 33

A New Senior Housing Era Begins in Channahon If there's one thing the affordable housing game loves, it's the mix of ambition and grit—both of which Lincoln Avenue Communities (LAC) brings to the table with The Talia. This latest project in Channahon, Illinois, marks their fourth groundbreaking in the state, cementing LAC's place as a key player in providing quality...

Continue Reading
Kim Dunbar Sheds Light on Online Personalized Learning

Updated Category News Views 11

Picture a classroom without walls, the teacher always available, and students moving at their own pace. Sounds utopian, right? Well, Virtual Public School Expert Kim Dunbar is making sense of this approach at SC Whitmore School in Columbia, South Carolina, as she explains how this works in an online high school. Mastery-Based Learning: Beyond the Conventional Rigid...

Continue Reading
Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026

Updated Category News Views 23

Neurocrine's Triple-Digit Surge Neurocrine Biosciences is on a tear, pushing its revenue up to a jaw-dropping $1.1 billion in Q3 2026—a hefty 41% leap from the previous year. Frankly, you can't ignore those numbers. INGREZZA, which is practically becoming a cash cow, did $801 million alone, rising 17% year over year. This rides the wave of prescription surges and solid...

Continue Reading
Dr. Huang's Honorary Degree Caps Global Impact Journey

Updated Category News Views 41

Recognition from Alma Mater Puts a Bow on a Storied Career When someone ventures out into the world and leaves a mark across continents, it’s a remarkable feat. It’s even more heartening when the place that helped shape them gets to extend a nod of recognition. Dr. Charles Huang, the mastermind behind Pasaca Capital, just unwound a new layer to his multicolored life...

Continue Reading
/neurocrine-biosciences-hits-1-billion-mark-in-q3-2026-540185-/" title="Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026 - Continue Reading" aria-label="Continue reading: Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026"> Continue Reading